SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+9.33%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$899M
AUM Growth
+$899M
(+31%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
11.33%
Top 10 Holdings %
Top 10 Hldgs %
65.2%
Holding
49
New
13
Increased
20
Reduced
8
Closed
8
Top Buys
| 1 |
Bausch Health
BHC
|
$132M |
| 2 |
AGN
Allergan plc
AGN
|
$38.9M |
| 3 |
Centene
CNC
|
$17.1M |
| 4 |
Universal Health Services
UHS
|
$16.2M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$10.2M |
Top Sells
| 1 |
Viatris
VTRS
|
$50.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$35.3M |
| 3 |
Amgen
AMGN
|
$28.7M |
| 4 |
Cigna
CI
|
$23.4M |
| 5 |
STJ
St Jude Medical
STJ
|
$22.4M |
Sector Composition
| 1 | Healthcare | 87.72% |
| 2 | Financials | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bausch Health
BHC
$2.74B
| $132M | 14.68% | +1,299,056 | New | +$132M |
|
|
NVRO
2
DELISTED
NEVRO CORP.
NVRO
| $114M | 12.63% | 1,682,877 -522,304 | -24% | -$35.3M |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $84.1M | 9.35% | 1,281,189 +66,695 | +5% | +$4.38M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $57.9M | 6.44% | 535,532 +42,128 | +9% | +$4.55M |
|
|
5
Viatris
VTRS
$12.3B
| $42.5M | 4.72% | 785,284 -933,900 | -54% | -$50.5M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $38.9M | 4.33% | +124,500 | New | +$38.9M |
|
|
TVTY
7
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $32.5M | 3.61% | 2,525,044 +406,007 | +19% | +$5.23M |
|
|
STJ
8
DELISTED
St Jude Medical
STJ
| $31.3M | 3.48% | 506,900 -363,400 | -42% | -$22.4M |
|
|
CNCE
9
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $27.2M | 3.02% | 1,432,617 -213,056 | -13% | -$4.04M |
|
10
Biogen
BIIB
$19.4B
| $26.4M | 2.94% | 86,300 -3,200 | -4% | -$980K |
|
|
MNK
11
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $21.8M | 2.42% | 291,940 -138,260 | -32% | -$10.3M |
|
|
ACOR
12
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $21.6M | 2.4% | 504,253 +239,500 | +90% | +$10.2M |
|
13
ANI Pharmaceuticals
ANIP
$2.03B
| $20.5M | 2.28% | 453,852 +183,812 | +68% | +$8.29M |
|
14
Travere Therapeutics
TVTX
$1.56B
| $20.4M | 2.27% | 1,058,882 +336,782 | +47% | +$6.5M |
|
|
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $19M | 2.11% | 352,924 -203,300 | -37% | -$10.9M |
|
|
ALDR
16
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $18.4M | 2.05% | 557,170 +7,270 | +1% | +$240K |
|
|
17
Centene
CNC
$14.3B
| $17.1M | 1.9% | +260,000 | New | +$17.1M |
|
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $16.5M | 1.83% | 1,092,512 +70,000 | +7% | +$1.05M |
|
|
19
Universal Health Services
UHS
$11.6B
| $16.2M | 1.8% | +135,200 | New | +$16.2M |
|
20
Insmed
INSM
$28.8B
| $12.5M | 1.39% | 689,107 +113,700 | +20% | +$2.06M |
|
|
FOMX
21
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $12.1M | 1.35% | 1,497,431 +633,023 | +73% | +$5.13M |
|
22
Tandem Diabetes Care
TNDM
$845M
| $11M | 1.22% | 930,049 +64,400 | +7% | +$761K |
|
|
ELOS
23
DELISTED
Syneron Medical Ltd
ELOS
| $10.8M | 1.21% | 1,406,282 +214,772 | +18% | +$1.66M |
|
|
CORI
24
DELISTED
Corium International, Inc.
CORI
| $10.7M | 1.19% | 1,321,479 +116,758 | +10% | +$948K |
|
|
DERM
25
DELISTED
Dermira, Inc.
DERM
| $8.57M | 0.95% | 247,500 -47,800 | -16% | -$1.65M |
|